8-K: Tivic Health Formalizes CEO Jennifer Ernst's Employment Terms

Tivic Health Systems, Inc. has formalized a new executive employment agreement with CEO Jennifer Ernst, outlining updated compensation and severance terms.

Summary

• A new executive employment agreement was entered into with Jennifer Ernst, the Chief Executive Officer, effective October 8, 2025.
• The new agreement replaces and supersedes the previous executive offer letter dated July 31, 2021.
• Ms. Ernst's base salary is set at $325,000 per annum, subject to review and adjustment.
• She is eligible for an annual end-of-year incentive bonus of up to 50% of her base salary, at the Board's discretion, contingent on performance and company objectives.
• Eligibility for annual focal grants under the company's Amended and Restated 2021 Equity Incentive Plan is maintained.
• Employment remains at-will, allowing termination by either party at any time, with or without cause.
• Severance benefits are provided if Ms. Ernst terminates for 'good reason' or the company terminates her employment 'without cause'.
• Severance includes 1/12 of her base salary per month for twelve months, company-paid COBRA coverage for twelve months, and continued vesting of unvested equity awards for twelve months post-termination.
• No severance benefits are provided for voluntary resignation (other than for good reason), termination for cause, death, or disability.
• All incentive compensation is subject to clawback in accordance with company policies and applicable law.
• The Confidentiality Agreement and Arbitration Agreement, both dated July 31, 2021, remain in full force and effect.

Sentiment

Score: 6

Explanation: The filing is largely neutral, as it formalizes an existing employment relationship. It provides clarity on executive compensation and severance, which is a positive for corporate governance, but does not introduce new strategic or financial information that would significantly alter the company's outlook. The structured compensation and severance terms can be seen as a positive for executive retention and stability.

Positives

• Formalizes the employment terms for a key executive, providing clarity and stability in leadership.
• The compensation structure, including base salary, discretionary bonus, and equity eligibility, is competitive and designed to incentivize performance.
• Retention of the CEO is supported by a structured agreement, which can be positive for long-term strategic execution.

Negatives

• The company commits to a fixed base salary of $325,000, representing a guaranteed compensation component.
• Potential for significant severance payments and continued equity vesting for 12 months if the CEO is terminated without cause or resigns for good reason, which could be a financial burden.

Risks

• The 'at-will' nature of employment means the CEO can resign at any time, potentially disrupting company operations.
• The company faces financial exposure for severance and continued benefits if it terminates the CEO without cause, which could impact liquidity.
• The clawback provision for incentive compensation highlights the risk of financial restatements or executive misconduct that could necessitate recovery of past bonuses.

Future Outlook

The filing primarily details current employment terms and does not provide specific forward-looking statements regarding company performance, strategic initiatives, or financial guidance beyond the operational aspects of the CEO's compensation and potential severance.

Management Comments

• The Board of Directors has the sole discretion to determine the annual end-of-year incentive bonus amount for the CEO.
• The Board or Compensation Committee determines eligibility for annual focal grants under the company's Amended and Restated 2021 Equity Incentive Plan.

Industry Context

Formalizing executive employment agreements is a standard practice in publicly traded companies, particularly for key leadership roles like CEO. The compensation structure, including base salary, performance-based bonuses, and equity incentives, aligns with typical industry standards for attracting and retaining executive talent in the health systems sector, especially for companies of Tivic Health's apparent size and stage.

Comparison to Industry Standards

• The base salary of $325,000 is generally within the range for CEOs of small-cap public companies, though specific comparisons would require detailed analysis of peer groups based on market capitalization, revenue, and industry segment.
• A discretionary annual bonus of up to 50% of base salary is a common incentive structure, comparable to practices at companies like smaller medical device firms or emerging biotech companies, where performance metrics are often tied to product development, regulatory milestones, or revenue growth.
• The provision for 12 months of severance and continued equity vesting upon involuntary termination is a standard executive protection clause, often seen in employment agreements across various industries to provide a safety net for executives and facilitate smooth transitions.

Corporate Governance

Related Party Transactions

• The employment agreement with Jennifer Ernst, the Chief Executive Officer, constitutes a related party transaction as it involves compensation and terms for a key management personnel.

Stakeholder Impact

• Shareholders: Gain clarity on CEO compensation structure, potential severance costs, and the formalization of executive leadership terms, which can contribute to governance transparency.
• Employees: The formalization of the CEO's role and compensation may signal stability in leadership.
• Management: The CEO's role, responsibilities, and compensation are clearly defined, providing a framework for her continued service.

Next Steps

• Jennifer Ernst will continue her role as CEO under the terms of the new employment agreement.
• The Board of Directors will periodically review and potentially adjust the CEO's base salary based on performance.
• The Board or Compensation Committee will determine annual incentive bonuses and focal equity grants based on company and personal objectives.

Key Dates

Recommendation

The filing details a new employment agreement for the CEO, which is a standard corporate governance action. While it formalizes compensation and severance, it does not introduce new strategic initiatives, financial performance updates, or significant operational changes that would materially alter the company's investment profile. It primarily provides clarity on executive terms, which is generally a neutral event for stock valuation, hence a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Executive Employment Agreement, CEO Compensation, Jennifer Ernst, Tivic Health Systems, SEC Filing, Corporate Governance, Severance Package, Equity Incentive Plan, Nasdaq